These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6142811)

  • 21. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does B-HT 920 lower intraocular pressure in cats by interacting with alpha 2- and/or DA2 adrenoceptors?
    Potter DE; Burke JA
    J Ocul Pharmacol; 1985; 1(1):29-45. PubMed ID: 2906078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in the rabbit.
    Krootila K; Palkama A; Uusitalo H
    J Ocul Pharmacol; 1987; 3(4):279-90. PubMed ID: 3503917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors.
    Ogidigben MJ; Chu TC; Potter DE
    Exp Eye Res; 2001 Mar; 72(3):331-9. PubMed ID: 11180982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can UK-14, 304-18 lower IOP in rabbits by a peripheral mechanism?
    Burke J; Crosson C; Potter D
    Curr Eye Res; 1989 Jun; 8(6):547-52. PubMed ID: 2743793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys.
    Burke JA; Potter DE
    Curr Eye Res; 1986 Sep; 5(9):665-76. PubMed ID: 2876846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of topical natural ergot alkaloids on intraocular pressure and aqueous humor dynamics in ocular normotensive rabbits.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    J Ocul Pharmacol Ther; 2002 Feb; 18(1):41-52. PubMed ID: 11858614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential sites of action of TNPA: a dopamine-2 receptor agonist.
    Chu E; Chu TC; Potter DE
    Exp Eye Res; 1999 Dec; 69(6):611-6. PubMed ID: 10620390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Central ocular hypotensive effect of noradrenaline].
    Nakajima K; Ohno J; Ueda T; Inatomi M; Koide R; Kiuchi Y; Oguchi K; Ueda T; Uchida E; Yasuhara H
    Nippon Ganka Gakkai Zasshi; 1995 Jun; 99(6):649-52. PubMed ID: 7610999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of three dopamine agonists on cage climbing behavior.
    Gianutsos G; Palmeri JL
    Psychopharmacology (Berl); 1983; 79(4):329-31. PubMed ID: 6134299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
    Alarma-Estrany P; Crooke A; Mediero A; Peláez T; Pintor J
    J Pineal Res; 2008 Nov; 45(4):468-75. PubMed ID: 18673419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of topical dihydroergocristine on intraocular pressure, aqueous humor dynamics and pupil diameter in conscious rabbits. A comparative study with timolol and pilocarpine.
    Santafé Oroz J; Segarra Domenech J; Garrido García M; Pablo Martínez V
    Methods Find Exp Clin Pharmacol; 1991 May; 13(4):231-8. PubMed ID: 1908543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS; Novak PJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):93-105. PubMed ID: 6141774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of central dopamine receptors in the hypotensive action of pergolide.
    Jadhav AL; Willett RN; Sapru HN; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):281-6. PubMed ID: 6664381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits.
    Potter DE; Burke JA; Ogidigben MJ
    J Auton Pharmacol; 1990 Jun; 10(3):153-61. PubMed ID: 1974256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits.
    Chu TC; Han P; Han G; Potter DE
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):9-17. PubMed ID: 10048343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aminotetralins on intraocular pressure and pupillary function in rabbits.
    Burke JA; Chang FW; Potter DE
    J Auton Pharmacol; 1984 Sep; 4(3):185-92. PubMed ID: 6490680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent.
    Chu TC; He Q; Potter DE
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):507-14. PubMed ID: 12537677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ibuterol, a beta-2 adrenergic prodrug, on intraocular pressure.
    Phipps TL; Potter DE; Rowland JM
    J Ocul Pharmacol; 1986; 2(3):225-37. PubMed ID: 3503109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.